The finding is that plasma NfL is superior to plasma t-tau, for the purposes of diagnosis of frontotemporal lobar degeneration syndromes (FTLD-S), diagnosis of Alzheimer disease syndromes (AD-S), prediction of clinical progression of FTLD-S, and prediction of clinical progression of AD-S. The gene discussed is NEFL; the disease is Alzheimer disease.